Elemind Secures $12M in Seed Funding to Pioneer Electric Medicine with AI-Powered Wearable Neurotechnology
Elemind is at the forefront of neurotech health, developing non-invasive wearable technology to monitor and address neurological issues through real-time brainwave analysis and tailored stimulation.
Company Name: Elemind
Location: Cambridge, MA
Sector: Neurotechnology Health
Funding Details: Raised $12M in Seed funding from Village Global, LDV Partners, E14 Fund, Wharton’s Alumni Angel fund, Embark Ventures, and notable founders from Skype, Nest, Opentable, Broadvision, Boston Scientific, Vital Proteins, and Fab Fit Fun.
Purpose of Investment: To further develop and launch their first product, focusing on electric medicine using wearable neurotechnology.
Leadership: CEO Meredith Perry, with a founding team including Dr. Ed Boyden, Dr. David Wang, Dr. Ryan Neely, Dr. Nir Grossman, and Dr. Heather Read.
Product: Elemind is developing wearable neurotechnology that reads individual brainwaves and guides them in real-time by responding with tailored stimulation, pioneering the field of "electric medicine."
About Company: Elemind is at the forefront of neurotech health, developing non-invasive wearable technology to monitor and address neurological issues through real-time brainwave analysis and tailored stimulation. The founding team brings a wealth of experience from neurotechnology, AI, and neuroscience
